干细胞作为结直肠癌的治疗靶点。
Stem cells as therapeutic targets in colorectal cancer.
机构信息
Department of Surgery, Thomas Jefferson University Hospital, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.
Department of Pharmacology & Experimental Therapeutics, Thomas Jefferson University, 1020 Locust St, JAH368, Philadelphia, PA 19107, USA.
出版信息
Per Med. 2021 Mar;18(2):171-183. doi: 10.2217/pme-2020-0099. Epub 2021 Feb 10.
Abstract
Colorectal cancer continues to represent a significant burden on public health as the second highest cause of cancer mortality, when men and women are combined, in the US. About 50% of patients either present with late-stage metastatic disease, or develop metastatic recurrences, and ultimately die. In turn, this mortality largely reflects cancer stem cells, tumor-initiating cells that are responsible for cancer progression, drug resistance, recurrence and metastasis. This review summarizes the unique properties of colorectal cancer stem cells, and the emerging strategies by which they can be selectively targeted as a therapeutic approach to eradicating this disease.
摘要
结直肠癌在美国仍是男性和女性癌症死亡的第二大主要原因，给公众健康带来了巨大负担。约有 50%的患者要么出现晚期转移性疾病，要么出现转移性复发，最终死亡。反过来，这种死亡率在很大程度上反映了癌症干细胞，即负责癌症进展、耐药性、复发和转移的肿瘤起始细胞。本文综述了结直肠癌干细胞的独特特性，以及新兴的靶向这些细胞的策略，作为消除这种疾病的一种治疗方法。
相似文献
1
Stem cells as therapeutic targets in colorectal cancer.干细胞作为结直肠癌的治疗靶点。
Per Med. 2021 Mar;18(2):171-183. doi: 10.2217/pme-2020-0099. Epub 2021 Feb 10.
2
Targeting Jak/Stat pathway as a therapeutic strategy against SP/CD44+ tumorigenic cells in Akt/β-catenin-driven hepatocellular carcinoma.针对 Akt/β-catenin 驱动的肝癌中 SP/CD44+致瘤细胞的 Jak/Stat 通路作为一种治疗策略。
J Hepatol. 2020 Jan;72(1):104-118. doi: 10.1016/j.jhep.2019.08.035. Epub 2019 Sep 18.
3
Biology of colorectal cancer.结直肠癌的生物学特性
Cancer J. 2010 May-Jun;16(3):196-201. doi: 10.1097/PPO.0b013e3181e076af.
4
[Signal pathways in breast cancer stem cells and the targeted stem cell therapy].[乳腺癌干细胞中的信号通路与靶向干细胞治疗]
Zhonghua Zhong Liu Za Zhi. 2010 Dec;32(12):881-5.
5
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer.Wnt/β-连环蛋白、刺猬信号、Notch和PI3K信号通路中的突变对GSK-3活性的影响——对细胞生长、代谢和癌症的多种影响
Biochim Biophys Acta. 2016 Dec;1863(12):2942-2976. doi: 10.1016/j.bbamcr.2016.09.004. Epub 2016 Sep 6.
6
Identification of inhibitory immune checkpoints and relevant regulatory pathways in breast cancer stem cells.鉴定乳腺癌干细胞中的抑制性免疫检查点和相关调控通路。
Cancer Med. 2021 Jun;10(11):3794-3807. doi: 10.1002/cam4.3902. Epub 2021 May 1.
7
Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer.Jagged1是结直肠癌中Wnt和Notch信号通路之间的病理联系。
Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6315-20. doi: 10.1073/pnas.0813221106. Epub 2009 Mar 26.
8
Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications.肝癌中癌症干细胞的表观遗传调控：当前概念和临床意义。
J Hepatol. 2010 Sep;53(3):568-77. doi: 10.1016/j.jhep.2010.05.003. Epub 2010 May 31.
9
Study of the aqueous extract of Aloe vera and its two active components on the Wnt/β-catenin and Notch signaling pathways in colorectal cancer cells.研究芦荟的水提物及其两种活性成分对结直肠癌细胞中 Wnt/β-catenin 和 Notch 信号通路的影响。
J Ethnopharmacol. 2019 Oct 28;243:112092. doi: 10.1016/j.jep.2019.112092. Epub 2019 Jul 15.
10
Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.通过转录增强子失活沉默人结直肠癌细胞中的 EPHB3 肿瘤抑制基因。
Proc Natl Acad Sci U S A. 2014 Apr 1;111(13):4886-91. doi: 10.1073/pnas.1314523111. Epub 2014 Mar 18.
引用本文的文献
1
Adoptive cell therapy in colorectal cancer: Advances in chimeric antigen receptor T cells.结直肠癌中的过继性细胞疗法：嵌合抗原受体T细胞的进展
World J Gastrointest Oncol. 2025 Jul 15;17(7):106723. doi: 10.4251/wjgo.v17.i7.106723.
2
Suppression of Metastasis of Colon Cancer to Liver in Mouse Models by Pretreatment with Extracellular Vesicles Derived from -Overexpressing Colon-26 Cancer Cells.用源自过表达结肠-26癌细胞的细胞外囊泡预处理对小鼠模型中结肠癌肝转移的抑制作用
Int J Mol Sci. 2024 Nov 28;25(23):12794. doi: 10.3390/ijms252312794.
3
Epigenetic modulation of autophagy pathway by small molecules in colorectal cancer: a systematic review.小分子通过表观遗传调控在结直肠癌自噬通路中的作用：系统综述。
J Cancer Res Clin Oncol. 2024 Oct 23;150(10):474. doi: 10.1007/s00432-024-05982-1.
4
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies.从隐窝到癌症：结直肠癌发生和治疗策略的整体观点。
Int J Mol Sci. 2024 Aug 30;25(17):9463. doi: 10.3390/ijms25179463.
5
The Role of Tumor Stem Cells in Colorectal Cancer Drug Resistance.肿瘤干细胞在结直肠癌药物耐药中的作用。
Cancer Control. 2024 Jan-Dec;31:10732748241274196. doi: 10.1177/10732748241274196.
6
The Impact of Cancer Stem Cells in Colorectal Cancer.癌症干细胞在结直肠癌中的影响
Int J Mol Sci. 2024 Apr 9;25(8):4140. doi: 10.3390/ijms25084140.
7
Links WNT and Retinoic Acid Signaling: A Target to Differentiate ALDH+ Stem Cells in -Mutant CRC.WNT与视黄酸信号通路的联系：一种在β-连环蛋白突变型结直肠癌中分化ALDH+干细胞的靶点。
Cancers (Basel). 2024 Jan 7;16(2):264. doi: 10.3390/cancers16020264.
8
Regulation of the migration of colorectal cancer stem cells via the TLR4/MyD88 signaling pathway by the novel surface marker CD14 following LPS stimulation.新型表面标志物CD14在脂多糖刺激后通过TLR4/MyD88信号通路对结直肠癌干细胞迁移的调控
Oncol Lett. 2023 Dec 18;27(2):60. doi: 10.3892/ol.2023.14194. eCollection 2024 Feb.
9
How the interplay among the tumor microenvironment and the gut microbiota influences the stemness of colorectal cancer cells.肿瘤微环境与肠道微生物群之间的相互作用如何影响结肠癌细胞的干性。
World J Stem Cells. 2023 May 26;15(5):281-301. doi: 10.4252/wjsc.v15.i5.281.
10
Cell Therapy as Target Therapy against Colon Cancer Stem Cells.细胞治疗作为针对结肠癌干细胞的靶向治疗。
Int J Mol Sci. 2023 May 3;24(9):8163. doi: 10.3390/ijms24098163.
本文引用的文献
1
Targeting cancer stem cell pathways for cancer therapy.针对癌症干细胞通路的癌症治疗。
Signal Transduct Target Ther. 2020 Feb 7;5(1):8. doi: 10.1038/s41392-020-0110-5.
2
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer.结直肠癌免疫图谱、遗传亚型与免疫治疗应答的关系。
Front Immunol. 2020 Mar 6;11:369. doi: 10.3389/fimmu.2020.00369. eCollection 2020.
3
Therapeutic potential of FLANC, a novel primate-specific long non-coding RNA in colorectal cancer.FLANC，一种新型灵长类特异性长非编码 RNA 在结直肠癌中的治疗潜力。
Gut. 2020 Oct;69(10):1818-1831. doi: 10.1136/gutjnl-2019-318903. Epub 2020 Jan 27.
4
Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer.嵌合抗原受体T细胞疗法治疗结直肠癌
J Clin Med. 2020 Jan 9;9(1):182. doi: 10.3390/jcm9010182.
5
The Cross Talk between Cancer Stem Cells/Cancer Initiating Cells and Tumor Microenvironment: The Missing Piece of the Puzzle for the Efficient Targeting of these Cells with Immunotherapy.癌症干细胞/癌症起始细胞与肿瘤微环境之间的相互作用：免疫疗法有效靶向这些细胞的关键缺失环节。
Cancer Microenviron. 2019 Dec;12(2-3):133-148. doi: 10.1007/s12307-019-00233-1. Epub 2019 Nov 22.
6
LncRNAs as Regulators of Autophagy and Drug Resistance in Colorectal Cancer.长链非编码RNA作为结直肠癌自噬和耐药性的调节因子
Front Oncol. 2019 Oct 2;9:1008. doi: 10.3389/fonc.2019.01008. eCollection 2019.
7
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance.JAK2/STAT3/CCND2 轴促进结直肠癌干细胞的持续存在和放射抵抗。
J Exp Clin Cancer Res. 2019 Sep 11;38(1):399. doi: 10.1186/s13046-019-1405-7.
8
Biomarker targeting of colorectal cancer stem cells.结直肠癌干细胞的生物标志物靶向治疗
Biomark Med. 2019 Aug;13(11):891-894. doi: 10.2217/bmm-2019-0227. Epub 2019 Aug 6.
9
RUNX3 suppresses metastasis and stemness by inhibiting Hedgehog signaling in colorectal cancer.RUNX3通过抑制结直肠癌中的Hedgehog信号通路来抑制转移和干性。
Cell Death Differ. 2020 Feb;27(2):676-694. doi: 10.1038/s41418-019-0379-5. Epub 2019 Jul 5.
10
Regulatory mechanisms of microRNAs in colorectal cancer and colorectal cancer stem cells.微小 RNA 在结直肠癌和结直肠癌细胞中的调控机制。
J Cell Physiol. 2020 Feb;235(2):776-789. doi: 10.1002/jcp.29042. Epub 2019 Jul 1.
Zotero 插件